<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27872711</article-id><article-id pub-id-type="pmc">5110663</article-id><article-id pub-id-type="publisher-id">IJBMS-19-1136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Ozone therapy could attenuate tubulointerstitial injury in adenine-induced CKD rats by mediating Nrf2 and NF-&#x003ba;B</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Gang</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiuheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhiyuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhishun</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Weng</surname><given-names>Xiaodong</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China</aff><author-notes><corresp id="cor1"><label>*</label><italic>Corresponding author:</italic> Xiuheng Liu. Department of Urology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, Hubei, China, 430060. email: <email xlink:href="drxhliu@yeah.net">drxhliu@yeah.net</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2016</year></pub-date><volume>19</volume><issue>10</issue><fpage>1136</fpage><lpage>1143</lpage><history><date date-type="received"><day>31</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Basic Medical Sciences</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective(s):</title><p>This study aims to determine the effects of ozone therapy on restoring impaired Nrf2 activation to ameliorate chronic tubulointerstitial injury in rats with adenine-induced CKD.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Sprague&#x02013;Dawley rats were fed with 0.75% adenine-containing diet to induce CKD and chronic tubulointerstitial injury. Ozone therapy was administered by rectal insufflation. After 4 weeks, serum and kidney samples were collected and analyzed. Renal function and systemic electrolyte level were detected. Pathological changes in kidney were assessed by hematoxylin&#x02013;eosin staining and Masson trichrome staining. Nrf2 activation was detected by immunohistochemistry and Western blot analyses. The levels of SOD, CAT, GSH, PCO, and MDA were detected in the kidney. Immunohistochemistry, Western blot, and real-time PCR analyses were performed to evaluate the activation of the nuclear factor kappa B (NF-&#x003ba;B) P65 pathway and inflammation infiltration in the tubulointerstitium of the rats.</p></sec><sec id="st3"><title>Results:</title><p>Ozone therapy improved severe renal insufficiency and tubulointerstitial morphology injury as well as restored Nrf2 activation and inhibited the NF-&#x003ba;B pathway in rats with adenine-induced CKD. Ozone therapy also up-regulated anti-oxidation enzymes (SOD, CAT, and GSH) and down-regulated oxidation products (PCO and MDA), as well as inflammatory cytokines (IL-1&#x003b2;, IL-6, TNF-&#x003b1;, and ICAM-1) in the kidney.</p></sec><sec id="st4"><title>Conclusion:</title><p>These findings indicated that ozone therapy could attenuate tubulointerstitial injury in rats with adenine-induced CKD by mediating Nrf2 and NF-&#x003ba;B.</p></sec></abstract><kwd-group><kwd>Adenine</kwd><kwd>Nuclear factor erythroid-2-related factor 2</kwd><kwd>Ozone therpy</kwd><kwd>Rat</kwd><kwd>Tubuleinterstitial injury</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Chronic kidney disease (CKD), an irreversible disease that results in end-stage renal failure (<xref rid="ref1" ref-type="bibr">1</xref>), has been a substantial health concern for many years. According to the recent Global Burden of Disease study, CKD ranked 27th in 1990 but increased to 18th in 2010 in the list of the leading causes of death worldwide (<xref rid="ref2" ref-type="bibr">2</xref>); as such, the economic burden caused by CKD has increased. Thus far, except expensive renal replacement therapy, only few effective therapy agents have been developed for treatment of CKD in recent years (<xref rid="ref3" ref-type="bibr">3</xref>). Therefore, new therapy agents especially those cost-effective medical treatments are required by international medical community (<xref rid="ref3" ref-type="bibr">3</xref>, <xref rid="ref4" ref-type="bibr">4</xref>).</p><p>Irrespective of primary diseases, chronic tubuleinterstitial injury is a common pathway aggrevating CKD (<xref rid="ref5" ref-type="bibr">5</xref>, <xref rid="ref6" ref-type="bibr">6</xref>). Studies revealed that impaired Nrf2 activation, which results in diseased anti-oxidative system and oxidation-mediated injury, is one of critical causes that lead to chronic tubulointerstitial injury in CKD(<xref rid="ref7" ref-type="bibr">7</xref>, <xref rid="ref8" ref-type="bibr">8</xref>). As the main guard defending oxidative stress injury in organs. Nrf2 generally forms a multimer with Kelch-like ECH-associated protein1 (Keap1) to maintain an inactive state, but Nrf2 would release from the multimer and bind to the sites of antioxidant response element (ARE) or electrophile-responsive element (EpRE) in nucleus when cells are exposed to oxidative stress. This condition, in turn, mobilizes antioxidant enzymes and II phase detoxification enzyme to resist insults (<xref rid="ref9" ref-type="bibr">9</xref>). In addition, promoting Nrf2 activation also suppresses inflammation by negatively mediating nuclear factor-kappa B (NF-&#x003ba;B) signaling pathway in some diseases (<xref rid="ref10" ref-type="bibr">10</xref>). Therefore, treatment involving restoring the impaired Nrf2 system could be a strategy to alleviate tubulointerstitial injury induced by oxidative stress and inflammation in CKD.</p><p>Ozone is a toxic gas but could be a safe therapeutic agent if applied in suitable amounts (<xref rid="ref11" ref-type="bibr">11</xref>). Ozone therapy has been widely accepted by medical community as a safe and cost-effective treatment for many diseases such as organ ischemia reperfusion injury and skin ulcer (<xref rid="ref12" ref-type="bibr">12</xref>-<xref rid="ref15" ref-type="bibr">15</xref>). Lately, some researches proved ozone therapy could activate Nrf2 of peripheral blood mononuclear cells and human endothelial cells in healthy human to defend insults (<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref17" ref-type="bibr">17</xref>). However, no study has investigated if ozone therapy could attenuate chronic tubulointerstitial injury in CKD by regulating impaired Nrf2 activation. Hence, this study aims to investigate this subject by creating a rodent model of CKD induced by adenine diet.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Animals and experimental design</title><p>Male Sprague-Dawley rats weighting about 180-200 g (8 weeks of age) were obtained from Animal Experimental Center of Tongji Medical College, Wuhan, China. The rats were housed in a room with a stable temperature of 22-23 &#x000b0;C, humidity at 50%-60% and a 12:12-hr light-dark cycle. The rats were fed with a standard diet and water <italic>ad libitum</italic>. All the experiment procedures were approved by the Experiment Animal Center Committee in Wuhan University, and the procedure was performed in accordance with the international animal care guidelines.</p><p>According to previous researches (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>), the rats were fed with 0.75% adenine diet for 4 weeks to induce tubuleinterstitiun injury and irreversible CKD. As previous researches described (<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref20" ref-type="bibr">20</xref>), ozone therpy was conducted with YKS-1000 g ozone therapeutic instrument (Ikou Co, Ltd, Zhuhai, China) to generate 3% ozone/oxygen gas mixture. The ozone concentration was set at 50 ug/ml. After determining the body weight of rats, we set the therapeutic dose to 1.1 mg/kg, which is proved to be safe and effective referring to the previous research (<xref rid="ref21" ref-type="bibr">21</xref>). The gas mixture was administrated through rectal insufflation using a polyethylene cannula.</p><p>After 7 days of acclimation, the rats were divided into 3 groups: 1) Sham group: rats were fed with normal diet only. 2) ADE group: rats were fed with 0.75% adenine diet and were not subjected to any treatment. 3) OT group: rats were fed with the same diet as ADE group, but simultaneously administrated with ozone therpy. The experiment was terminated after 4 weeks, all the rats were sacrificed 24 hr after ozone therapy. Blood and kidney samples were collected for further analysis.</p></sec><sec id="sec2-2"><title>Biochemical analysis</title><p>Serum creatinine (Cr), urea nitrogen (BUN) and electrolyte including potassium (K), inorganic phosphorus (IP) and total calcium (Ca) were measured by standard techniques using an Olympus AU 2700 Analyzer (Olympus Optical Co, Ltd, Tokyo, Japan).</p><p>Kidney tissue was sequentially rinsed with PBS (0.01 M, pH=7.4), weighted and homogenized in PBS. Then the homogenate was centrifuged at 5000 rpm for 10 min at 4 &#x000b0;C. After that, the supernatant was collected to detect SOD, CAT, GSH, MDA, PCO concentration by using corresponding commercial assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer instruction. Absorbance of SOD, CAT and GSH was respectively measured at 450 nm, 405 nm and 450 nm, while absorbance of MDA and PCO was respectively determined at 532 nm and 370 nm by using a spectrometer. Results were normalized to the total protein concentrations of renal tissue homogenate samples measured with Coomassie blue method by using assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).</p></sec><sec id="sec2-3"><title>Pathological analysis</title><p>The kidney was embedded with paraffin after 24 hr of paraformaldehyde fixation and sectioned to slides at 3 &#x003bc;m thick. The slides were subjected to hematoxylin&#x02013;eosin (H&#x00026;E) staining and Masson trichrome (MT) staining and then assessed under a microscope.</p><p>Immunohistochemical staining was performed. The slides were deparaffinized in xylene and rehydrated with ethanol gradient washes. Hydrogen peroxide (3%) was applied to activate endogenous hydrogen peroxide. The slides were sequentially retrieved using antigen microwave retrieval technique in a citrate buffer solution and blocked with 10% normal goat serum. The slides were incubated with primary antibodies against Nrf2 (ab31163; Abcam, Cambridge, MA, USA) and p-NF-&#x003ba;B P65 (sc-33020, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4&#x000b0;C overnight. After washing three times with PBS, the slides were incubated with HRP-conjugated antibody at room temperature for 30 min. Diaminobenzidine was used to color the slides. Staining was controlled under the microscope, and the reaction was terminated by washing with distilled water. The slides were counterstained with hematoxylin and assessed under a microscope.</p></sec><sec id="sec2-4"><title>Western blot analysis</title><p>Cytoplasmic and nuclear proteins were extracted from the frozen kidney by using OP-0002 and OP-0006 EpiQuik&#x02122; protein extraction kit (Epigentek, Farmingdale, NY, USA), respectively, according to the manufacturer&#x02019;s instruction. Protein concentration was determined using a Bradford protein assay reagent kit (Bio-Rad, Richmond, CA, USA) according to the manufacturer&#x02019;s instruction. The extracted proteins were separated by SDS polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane and blocked with 5% non-fat milk in TBST buffer. The membranes were incubated with</p><p>primary antibodies against Nrf2 (ab31163; Abcam, Cambridge, MA, USA), p-I&#x003ba;B&#x003b1; (sc-101713; Santa Cruz Biotechnology, Santa Cruz, CA, USA), p-NF-&#x003ba;B P65 (sc-33020; Santa Cruz Biotechnology, Santa Cruz, CA, USA), ICAM-1 (sc-1511; Santa Cruz Biotechnology, Santa Cruz, CA, USA), TNF-&#x003b1; (ab6671; Abcam, Cambridge, MA, USA), IL-1&#x003b2; (sc-7884; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and IL-6 (sc-1266; Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 &#x000b0;C. After washing three times with TBST, the membranes were incubated with the secondary antibody conjugated with horseradish peroxidase (ZSGB-BIO, Beijing, China) for 1 hr at room temperature. The membranes were then washed four times. An enhanced chemiluminescence detection kit was applied to visualize specific bands. Quantity One software was employed to detect optical densities. The results were presented as ratios of the target protein to Histon H1 protein, Lamin B protein, or GAPDH protein and assessed with GraphPad Prism 5 software.</p></sec><sec id="sec2-5"><title>Real-time PCR analysis</title><p>Total RNA was extracted from frozen kidney using Trizol reagent (Invitrogen, Carlsbad, CA). RNA concentration was detected by spectrophotometer. Reverse transcription was performed with a cDNA synthesis kit (Takara, Kyoto, Japan) according to the manufacturer&#x02019;s instructions. A SYBR Green mix kit (Applied Biosystems, CA, USA) was applied in the PCR. A total of 25 &#x003bc;l of the PCR reaction mixture contained 12.5 &#x003bc;l of SYBR Green mix, 2 &#x003bc;l of cDNA (2&#x000d7;), 1 &#x003bc;l of the forward primer, 1 &#x003bc;l of the reverse primer, and 8.5 &#x003bc;l of ddH<sub>2</sub>O. The primers used are listed in <xref ref-type="table" rid="T1">Table 1</xref>. GAPDH was used as reference gene. PCR was performed with a Gene Cycler (Bio-Rad, CA, USA) under the following cycling conditions: initial denaturation at 94 &#x000b0;C for 5 min; followed by 35 <xref ref-type="table" rid="T1">Table 1</xref>. Primer list cycles of denaturation at 94 &#x000b0;C for 30 sec, annealing at 56&#x000b0;C for 30 sec, extension at 72&#x000b0;C for 1 min; and final extension at 72&#x000b0;C for 7 min. Data were presented as the ratio of genes to GAPDH mRNA and assessed with GraphPad Prism 5 software.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Primer list</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Gene</th><th align="center" colspan="2" rowspan="1">Sequence</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-1&#x003b2;</td><td align="center" valign="top" rowspan="1" colspan="1">Forward:5&#x02019;-CTGTGACTCGTGGGATGATG-3&#x02019; <break/>Reverse:5&#x02019;-AGGGATTTTGTCGTTGCTTG-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">211 bp</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-6</td><td align="center" valign="top" rowspan="1" colspan="1">Forward:5&#x02019;-AGTTGCCTTCTTGGGACTGA-3&#x02019; <break/>Reverse:5&#x02019;-ACAGTGCATCATCGCTGTTC-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">218 bp</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="center" valign="top" rowspan="1" colspan="1">Forward:5&#x02019;-TGCCTCAGCCTCTTCTCATT-3&#x02019; <break/>Reverse:5&#x02019;-GGGCTTGTCACTCGAGTTTT-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">180 bp</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ICAM-1</td><td align="center" valign="top" rowspan="1" colspan="1">Forward:5&#x02019;-TGTCAAACGGGAGATGAATGGT-3&#x02019; <break/>Reverse:5&#x02019;-GGCGGTAATAGGTGTAAATGGAC-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">185 bp</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GAPDH</td><td align="center" valign="top" rowspan="1" colspan="1">Forward:5&#x02019;-ACAGCAACAGGGTGGTGGAC-3&#x02019; <break/>Reverse:5&#x02019;-TTTGAGGGTGCAGCGAACTT-3&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">253 bp</td></tr></tbody></table></table-wrap></sec><sec id="sec2-6"><title>Statistics analysis</title><p>SPSS 17.0 was used for statistics analysis. Date was presented as mean&#x000b1;SEM. One-way ANOVA 3 Student&#x02013;Newman&#x02013;Keuls test was implemented to compare the means of the different groups. Pearson correlation analysis was applied to evaluate the correlation between the nuclear expression of Nrf2 and p-NF-&#x003ba;B P65 in experiment rats. <italic>P</italic>&#x0003c;0.05 was considered as statistically significance.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><sec id="sec2-7"><title>Effect of ozone therpy on renal function in experimental rats</title><p>Renal function was reflected by serum Cr, BUN, K, Ca and IP concentration. Compared with Sham group, Cr, BUN, K, Ca and IP level were all significantly higher in ADE group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="table" rid="T2">Table 2</xref>). OT group showed a significant decrease in these indexes than ADE group (<italic>P</italic>&#x0003c;0.05; <xref ref-type="table" rid="T2">Table 2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Serum biochemical parameters in different groups at week 4</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Serum biochemical indexes</th><th align="center" rowspan="1" colspan="1">Sham group</th><th align="center" rowspan="1" colspan="1">OT group</th><th align="center" rowspan="1" colspan="1">ADE group</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Cr (um/l)</td><td align="center" rowspan="1" colspan="1">30.33&#x000b1;3.88</td><td align="center" rowspan="1" colspan="1">128.22&#x000b1;14.41<xref ref-type="table-fn" rid="t2f1">*</xref></td><td align="center" rowspan="1" colspan="1">221.33&#x000b1;19.13<xref ref-type="table-fn" rid="t2f2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">BUN (um/l)</td><td align="center" rowspan="1" colspan="1">3.99&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">35.31&#x000b1;5.16<xref ref-type="table-fn" rid="t2f1">*</xref></td><td align="center" rowspan="1" colspan="1">64.03&#x000b1;7.70<xref ref-type="table-fn" rid="t2f2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">K (mmol/l)</td><td align="center" rowspan="1" colspan="1">4.71&#x000b1;0.21</td><td align="center" rowspan="1" colspan="1">5.35&#x000b1;0.54<xref ref-type="table-fn" rid="t2f1">*</xref></td><td align="center" rowspan="1" colspan="1">6.41&#x000b1;0.46<xref ref-type="table-fn" rid="t2f2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ca (mmol/l)</td><td align="center" rowspan="1" colspan="1">2.31&#x000b1;0.10</td><td align="center" rowspan="1" colspan="1">2.58&#x000b1;0.18<xref ref-type="table-fn" rid="t2f1">*</xref></td><td align="center" rowspan="1" colspan="1">2.81&#x000b1;0.18<xref ref-type="table-fn" rid="t2f2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">IP (mmol/l)</td><td align="center" rowspan="1" colspan="1">2.53&#x000b1;0.27</td><td align="center" rowspan="1" colspan="1">4.41&#x000b1;0.28<xref ref-type="table-fn" rid="t2f1">*</xref></td><td align="center" rowspan="1" colspan="1">4.79&#x000b1;0.36<xref ref-type="table-fn" rid="t2f2">#</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Date was represented by mean&#x000b1;SEM.</p></fn><fn id="t2f1"><label>*</label><p><italic>P</italic>&#x0003c;0.05, versus ADE group;</p></fn><fn id="t2f2"><label>#</label><p><italic>P</italic>&#x0003c;0.01, versus Sham group. Sham group: normal control group; OT group: ozone therapy group; ADE group: adenine-induced CKD group</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-8"><title>Effect of ozone therpy on tubuleinterstitial pathology</title><p>H&#x00026;E staining and MT staining were peformed to detect tubuleinterstitial pathological changes in experiment rats. Compared with Sham group, rats in ADE group developed more serious tubuleinters-titium injury, as evidenced by tubular expansion, loss of brush border of proximal tubules, tubular atrophy, serious inflammatory cells infiltration and terrible tubuleinerstitial fibrosis. However, no remarkable glomerular injury was observed (<xref ref-type="fig" rid="F1">Figure 1</xref>). Changes mentioned above were mainly observed in the kidney cortex. However, compared with ADE group, tubuleinterstitium injury significantly improved in OT group (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Effect of ozone therpy on tubuleinterstitium morphology at week 4. Hematoxylin and eosin staining was performed in the kidneys of different groups, original magnification x400 (A); Masson trichrome staining was performed in the kidneys of different groups, original magnification x200 (B). Sham: normal control group; OT: ozone therapy group; ADE: adenine-induced CKD group</p></caption><graphic xlink:href="IJBMS-19-1136-g001"/></fig></sec><sec id="sec2-9"><title>Effect of ozone therpy on anti-oxidation enzymes and oxidation productions in the kidneys of experimental rats</title><p>Some typical anti-oxidation enzymes and oxidation productions were detected to reflect changes in anti-oxidative and oxidative system in the kidneys of experimental rats. The level of anti-oxidation enzymes including SOD, CAT and GSH were significantly lower in ADE group than Sham group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="table" rid="T3">Table 3</xref>), while the levels of oxidative productions including MDA and PCO were significantly higher than Sham group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="table" rid="T3">Table 3</xref>). OT group showed a significant increase of SOD, CAT and GSH and a remarkable decrease of MDA and PCO as compared with ADE group (<italic>P</italic>&#x0003c;0.05; <xref ref-type="table" rid="T3">Table 3</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Renal concentration of biochemical parameters in different groups at week 4</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">SOD (U/mgprot)</th><th align="center" rowspan="1" colspan="1">CAT (U/mgprot)</th><th align="center" rowspan="1" colspan="1">GSH (&#x003bc;mol/gprot)</th><th align="center" rowspan="1" colspan="1">PCO (nmol/mgprot)</th><th align="center" rowspan="1" colspan="1">MDA (nmol/mgprot)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sham</td><td align="center" rowspan="1" colspan="1">4.53&#x000b1;0.36</td><td align="center" rowspan="1" colspan="1">95.93&#x000b1;6.95</td><td align="center" rowspan="1" colspan="1">15.27&#x000b1;2.05</td><td align="center" rowspan="1" colspan="1">2.59&#x000b1;0.68</td><td align="center" rowspan="1" colspan="1">0.77&#x000b1;0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">OT</td><td align="center" rowspan="1" colspan="1">1.26&#x000b1;0.15 <xref ref-type="table-fn" rid="t3f1">*</xref></td><td align="center" rowspan="1" colspan="1">17.35&#x000b1;1.36 <xref ref-type="table-fn" rid="t3f1">*</xref></td><td align="center" rowspan="1" colspan="1">9.13&#x000b1;1.68 <xref ref-type="table-fn" rid="t3f1">*</xref></td><td align="center" rowspan="1" colspan="1">8.07&#x000b1;1.33 <xref ref-type="table-fn" rid="t3f1">*</xref></td><td align="center" rowspan="1" colspan="1">1.80&#x000b1;0.09 <xref ref-type="table-fn" rid="t3f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">ADE</td><td align="center" rowspan="1" colspan="1">0.83&#x000b1;0.16 <xref ref-type="table-fn" rid="t3f2">#</xref></td><td align="center" rowspan="1" colspan="1">8.87&#x000b1;0.86 <xref ref-type="table-fn" rid="t3f2">#</xref></td><td align="center" rowspan="1" colspan="1">6.22&#x000b1;1.02 <xref ref-type="table-fn" rid="t3f2">#</xref></td><td align="center" rowspan="1" colspan="1">19.15&#x000b1;3.12 <xref ref-type="table-fn" rid="t3f2">#</xref></td><td align="center" rowspan="1" colspan="1">2.29&#x000b1;0.21 <xref ref-type="table-fn" rid="t3f2">#</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Date was represented by mean&#x000b1;SEM.</p></fn><fn id="t3f1"><label>*</label><p><italic>P</italic>&#x0003c;0.05, versus ADE group;</p></fn><fn id="t3f2"><label>#</label><p><italic>P</italic>&#x0003c;0.01, versus Sham group. Sham: normal control group; OT: ozone therapy group; ADE: adenine-induced CKD group.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-10"><title>Effect of ozone therpy on Nrf2 in the kidney of experimental rats</title><p>The Nrf2 activation in the tubule-interstitum of experiment rat was detected. Immunohistochemistry showed Nrf2 activation in tubuleinterstitium area was significantly suppressed in ADE group than Sham group, while the expression of Nrf2 in OT group was significantly increased when compared with ADE group (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Western blot results showed the nuclear protein expression of Nrf2 was remarkably down-regulated in ADE group than Sham group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="fig" rid="F2">Figure 2B</xref>), while the nuclear protein levels of Nrf2 was significantly up-regulated in OT group than ADE group (<italic>P</italic>&#x0003c;0.05; <xref ref-type="fig" rid="F2">Figure 2B</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Effect of ozone therpy on Nrf2 activation in the kidneys of different groups at week 4. Nrf2 activation in the tubule interstitium was detected by immunohistochemical staining (A). The nuclear protein level of Nrf2 in the kidney was detected by Western blot analysis (B). Date was represented by mean&#x000b1;SEM. * P&#x0003c;0.05, versus ADE group; # P&#x0003c;0.01, versus Sham group. Sham: normal control group; OT: ozone therapy group; ADE: adenine-induced CKD group</p></caption><graphic xlink:href="IJBMS-19-1136-g002"/></fig></sec><sec id="sec2-11"><title>Effect of ozone therpy on NF-&#x003ba;B-mediated inflammation in the kidneys of experimental rats</title><p>To determine the acitivation of NF-&#x003ba;B signaling pathway in the kidney of experiment rat, the expression of p-I&#x003ba;B&#x003b1; and nuclear p-NF-&#x003ba;B P65 were detected in this paper. Immunohistochemistry results showed p-NF-&#x003ba;B P65 was excessively expressed in the kidney of ADE group than in Sham group, mainly located in the nucleus of kidney tubule epithelial cell (<xref ref-type="fig" rid="F3">Figure 3A</xref>). However, the expression of p-NF-&#x003ba;B P65 in tubuleinterstitium of OT group was significantly decreased when compared with that of ADE group (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Western blot results showed the protein expression of cytoplasm p-I&#x003ba;B&#x003b1; and nucleus p-NF-&#x003ba;B P65 was remarkably increased in ADE group than Sham group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="fig" rid="F3">Figure 3B</xref>), while the levels of these proteins were significantly decreased in OT group than ADE group (<italic>P</italic>&#x0003c;0.05; <xref ref-type="fig" rid="F3">Figure 3B</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Effect of ozone therpy on NF-&#x003ba;B-mediated inflammation in the kidneys of different groups at week 4. P-NF-&#x003ba;B P65 expression in the tubule interstitium was detected by immunohistochemical staining (A). The protein level of p-I&#x003ba;B&#x003b1; and p-NF-&#x003ba;B P65 in the kidney was detected by western blot analysis (B). The protein level and mRNA level of TNF-&#x003b1;, IL-1&#x003b2;, IL-6 and ICAM-1 were respectively detected by Western blot analysis (C) and real-time PCR analysis (C). Date was represented by mean&#x000b1;SEM. *P&#x0003c;0.05, versus ADE group; **P&#x0003c;0.01, versus ADE group; # P&#x0003c;0.01, versus Sham group. Sham: normal control group; OT: ozone therapy group; ADE: adenine-induced CKD group</p></caption><graphic xlink:href="IJBMS-19-1136-g003"/></fig><p>Some typical inflammatory cytokines were also detected to reflect inflammation infiltration in the kidneys of experimental rats. The protein and mRNA levels of IL-1&#x003b2;, IL-6, TNF-&#x003b1; and ICAM-1 were significantly higher in ADE group than in Sham group (<italic>P</italic>&#x0003c;0.01; <xref ref-type="fig" rid="F3">Figure 3C</xref>). OT group showed a significant decrease of these inflammatory cytokines levels as compared with ADE group (<italic>P</italic>&#x0003c;0.05; <xref ref-type="fig" rid="F3">Figure 3C</xref>). The correlation between the nuclear expression of Nrf2 and p-NF-&#x003ba;B P65 in kidney:</p><p>As shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, the nuclear protein expression of Nrf2 was negatively correlated with the nucleus protein expression levels of p-NF-&#x003ba;B P65 in the kidneys of experiment rats.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>The relationship between the nucleus Nrf2 protein level and the nucleus p-NF-&#x003ba;B P65 protein level in the kidneys of experiment rats</p></caption><graphic xlink:href="IJBMS-19-1136-g004"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>A rat model of adenine-induced CKD was first established by Yokozawa and developed by many scientists. Previous studies reported that persistent 0.75% adenine-containing diet could lead to gradual accumulation of 2,8-dihydroxyadenine in renal tubules, which could induce chronic oxidative stress and inflammation; these phenomena could result in progressive deterioration of renal function and typical chronic tubulointerstitial injury which are similar to clinical patients with CKD(<xref rid="ref18" ref-type="bibr">18</xref>, <xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref22" ref-type="bibr">22</xref>). In this study, we developed a rat model of CKD induced by adenine and determined the efficacy of ozone therapy for alleviating chronic tubulointerstitial injury. The results of serum biochemical analysis showed that adenine-fed rats suffered severe renal insufficiency and electrolyte homeostasis disorder after a 4 week modeling period; hence, a rat model of severe CKD was successfully established Furthermore, H&#x00026;E staining and MT staining analyses indicated that the rats developed severe tubulointerstitial injury. A low dose of ozone therapy by rectal insufflation improved serum biochemical indices and alleviated renal tubulointerstitial injury in rats. These results indicated that long-term ozone therapy at low-dose rectal insufflation may exert a renoprotective action by alleviating tubulointerstitial injury in rats with adenine-induced CKD.</p><p>Excessive oxidative stress caused by functional decline in the anti-oxidation system is a crucial factor that causes tubulointerstitial injury in rats with adenine-induced CKD (<xref rid="ref23" ref-type="bibr">23</xref>, <xref rid="ref24" ref-type="bibr">24</xref>). In this study, the biochemical analysis on anti-oxidation enzymes and oxidation production indicated that persistent adenine diet disturbed redox homeostasis and caused serious oxidative stress injury in the kidney of experimental rats. However, ozone therapy reversed this condition by increasing the levels of SOD, CAT, and GSH, which are main defense enzymes against oxygen radical (<xref rid="ref25" ref-type="bibr">25</xref>, <xref rid="ref26" ref-type="bibr">26</xref>); the therapy also decreased the levels of MDA and PCO, which are typical oxidation products (<xref rid="ref27" ref-type="bibr">27</xref>), in the kidneys of rats with adenine-induced CKD. These results were consistent with other researchers&#x02019; results (<xref rid="ref28" ref-type="bibr">28</xref>-<xref rid="ref30" ref-type="bibr">30</xref>), who demonstrated that ozone therapy could increase the concentrations of anti-oxidative enzymes in other animal disease models. And based on these results, we considered that ozone therapy could enhance the activity of anti-oxidation system and ameliorate oxidative-stress injury oxidative-stress injury in the tubulointerstitium of rats with adenine-induced CKD.</p><p>This research is the first to study the effects of ozone therapy on impaired Nrf2 activation, which is considered the main factor that causes functional decline in anti-oxidant system in the tubulointerstitium of rats with adenine-induced CKD (<xref rid="ref7" ref-type="bibr">7</xref>). As showed in <xref ref-type="fig" rid="F2">Figure 2</xref>, Nrf2 expression in the tubulointerstitium of rats with adenine-induced CKD was suppressed, but ozone therapy up-regulated this expression. These results are consistent with the findings other, who reported that ozone therapy could improve Nrf2 activation in normal peripheral blood cells and human endothelial cells to resist insults (<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref17" ref-type="bibr">17</xref>). According to their studies, ozone therpy could reacts with polyunsaturated fatty acid to generate H<sub>2</sub>O<sub>2</sub> and alkenals including 4-hydroxynonenal, which in turn alters the cysteine residues of Keap1 to inhibit ubiquitin conjugation to Nrf2 by the Keap1 complex and stimulate the release and nuclear translocation of Nrf2 (<xref rid="ref16" ref-type="bibr">16</xref>, <xref rid="ref31" ref-type="bibr">31</xref>). Then the activated Nrf2 could induce the production of anti-oxidative enzymes such as SOD, CAT and GSH by binding to ARE in nucleus. As the health guardians, these free radical scavenging enzymes could convert peroxides including hydrogen peroxide and reactive oxygen radicals to harmless substances such as water and oxygen, eventually decrease lipid peroxidation products such as MDA and ameliorates oxidative stress injury(<xref rid="ref25" ref-type="bibr">25</xref>, <xref rid="ref32" ref-type="bibr">32</xref>). Hence, for the first time, we considered that ozone therapy may improve anti-oxidation activity by restoring impaired Nrf2 in the tubulointerstitium of rats with adenine-induced CKD.</p><p>Previous studies confirmed that chronic inflammation mediated by overactivation of I&#x003ba;B&#x003b1;/NF-&#x003ba;B pathway plays a pivotal role in aggravating chronic tubulointerstitial injury in rats with adenine-induced CKD (<xref rid="ref22" ref-type="bibr">22</xref>, <xref rid="ref24" ref-type="bibr">24</xref>). Ozone therapy could reduce inflammation injury in some animal disease models (<xref rid="ref33" ref-type="bibr">33</xref>, <xref rid="ref34" ref-type="bibr">34</xref>). In addition, Leon <italic>et al</italic> reported that the anti-inflammation effect of ozone therapy was obtained by inhibiting NF-&#x003ba;B activation (<xref rid="ref20" ref-type="bibr">20</xref>). In the present study, ozone therapy restrained the overactivation of p-I&#x003ba;B&#x003b1; and p-NF-&#x003ba;B P65 in the tubulointerstitium of rats with adenine-induced CKD; the therapy also reduced the levels of inflammatory cytokines, such as ICAM-1, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6, which were the downstream production of activation of I&#x003ba;B&#x003b1;/NF-kB pathway (<xref rid="ref35" ref-type="bibr">35</xref>, <xref rid="ref36" ref-type="bibr">36</xref>), in the kidneys of these rats. These results were consistent with our previous study (<xref rid="ref37" ref-type="bibr">37</xref>) and indicated that ozone therapy may attenuate tubulointerstitium inflammation by inhibiting NF-&#x003ba;B signaling pathway in rats with adenine-induced CKD.</p><p>The interaction between Nrf2 and I&#x003ba;B&#x003b1;/NF-&#x003ba;B pathway has gained increased research attention (<xref rid="ref38" ref-type="bibr">38</xref>, <xref rid="ref39" ref-type="bibr">39</xref>). Sun <italic>et al</italic> revealed that activating Nrf2 could inhibit the NF-&#x003ba;B signaling pathway to attenuate muscle inflammation in dystrophin-deficient mdx mice (<xref rid="ref40" ref-type="bibr">40</xref>). Further studies on lupus nephritis and neutrophilic lung inflammation through gene knockout technology revealed that Nrf2<sup>&#x02212;/&#x02212;</sup> rodent animals suffered more severe NF-&#x003ba;B-induced inflammation injury than the healthy controls (<xref rid="ref10" ref-type="bibr">10</xref>, <xref rid="ref41" ref-type="bibr">41</xref>). According to these researches, in addition to antioxidant activity, Nrf2 also exerts anti-inflammation activity by directly down-regulating the activation of the I&#x003ba;B&#x003b1;/NF-&#x003ba;B pathway or reducing oxidative stress, which could activate NF-&#x003ba;B. In this study, ozone therapy simultaneously restored impaired Nrf2 activation and suppressed NF-&#x003ba;B-mediated inflammation in the tubulointerstitium of rats with adenine-induced CKD. Moreover, as showed in <xref ref-type="fig" rid="F4">Figure 4</xref>, a negative relationship existed between the nuclear protein level of Nrf2 and p-NF-&#x003ba;B P65. Based on these results, the anti-inflammation property of ozone therapy may be partly achieved by restoring impaired Nrf2 activation in the tubulointerstitium of rats with adenine-induced CKD. However, the present evidence was insufficient to verify this assumption. Moreover, the present study did not evaluate the long-term effect of ozone therapy and consider different therapy concentrations and detection time points. Thus, further studies are needed to confirm and reveal the specific mechanisms involved in therapy for CKD.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>This study is the first to report that ozone therapy could improve chronic tubulointerstitial injury and exert renoprotection effect by restoring impaired Nrf2 activation and down-regulating NF-&#x003ba;B activation in rats with adenine-induced CKD. Based on this evidence and our previous study, we speculated that ozone therapy, which is a low-cost and effective non-drug treatment that has been clinically use for many years, may be a potential medical strategy to slow down disease progression in patients with CKD by alleviating chronic tubulointerstitial injury. However, further animal and clinical studies must be performed to confirm the results.</p></sec></body><back><ack><title>Acknowledgment</title><p>This study was supported by the Province Natural Science Foundation of Hubei (Grant No.2013CF B226).</p></ack><sec id="sec1-6"><title>Conflict of interest</title><p>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SI</given-names></name><name><surname>Choi</surname><given-names>ME</given-names></name></person-group><article-title>Therapeutic targets for treating fibrotic kidney diseases</article-title><source>Transl Res</source><year>2015</year><volume>165</volume><fpage>512</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">25176603</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>V</given-names></name><name><surname>Garcia-Garcia</surname><given-names>G</given-names></name><name><surname>Iseki</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Naicker</surname><given-names>S</given-names></name><name><surname>Plattner</surname><given-names>B</given-names></name><etal/></person-group><article-title>Chronic kidney disease: global dimension and perspectives</article-title><source>Lancet</source><year>2013</year><volume>382</volume><fpage>260</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">23727169</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remuzzi</surname><given-names>G</given-names></name><name><surname>Benigni</surname><given-names>A</given-names></name><name><surname>Finkelstein</surname><given-names>FO</given-names></name><name><surname>Grunfeld</surname><given-names>J-P</given-names></name><name><surname>Joly</surname><given-names>D</given-names></name><name><surname>Katz</surname><given-names>I</given-names></name><etal/></person-group><article-title>Kidney failure: aims for the next 10 years and barriers to success</article-title><source>Lancet</source><year>2013</year><volume>382</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">23727164</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckardt</surname><given-names>K-U</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Devuyst</surname><given-names>O</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>K&#x000f6;ttgen</surname><given-names>A</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Evolving importance of kidney disease: from subspecialty to global health burden</article-title><source>Lancet</source><year>2013</year><volume>382</volume><fpage>158</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">23727165</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eardley</surname><given-names>KS</given-names></name><name><surname>Zehnder</surname><given-names>D</given-names></name><name><surname>Quinkler</surname><given-names>M</given-names></name><name><surname>Lepenies</surname><given-names>J</given-names></name><name><surname>Bates</surname><given-names>RL</given-names></name><name><surname>Savage</surname><given-names>CO</given-names></name><etal/></person-group><article-title>The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease</article-title><source>Kidney Int</source><year>2006</year><volume>69</volume><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">16609683</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgkins</surname><given-names>KS</given-names></name><name><surname>Schnaper</surname><given-names>HW</given-names></name></person-group><article-title>Tubulointerstitial injury and the progression of chronic kidney disease</article-title><source>Pediatr Nephrol</source><year>2012</year><volume>27</volume><fpage>901</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">21947270</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Vaziri</surname><given-names>N</given-names></name></person-group><article-title>Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure</article-title><source>Am J Physiol Renal Physiol</source><year>2010</year><volume>298</volume><fpage>662</fpage><lpage>671</lpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>S</given-names></name><name><surname>Pergola</surname><given-names>PE</given-names></name><name><surname>Zager</surname><given-names>RA</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name></person-group><article-title>Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease</article-title><source>Kidney Int</source><year>2013</year><volume>83</volume><fpage>1029</fpage><lpage>1041</lpage><pub-id pub-id-type="pmid">23325084</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakabayashi</surname><given-names>N</given-names></name><name><surname>Slocum</surname><given-names>S</given-names></name><name><surname>Skoko</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Kensler</surname><given-names>T</given-names></name></person-group><article-title>When NRF2 Talks, Who's Listening?</article-title><source>Antioxid Redox Signal</source><year>2010</year><volume>13</volume><fpage>1649</fpage><lpage>1663</lpage><pub-id pub-id-type="pmid">20367496</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Whitman</surname><given-names>SA</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory response</article-title><source>Kidney Int</source><year>2014</year><volume>85</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">24025640</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocci</surname><given-names>V</given-names></name></person-group><article-title>Ozone as Janus: this controversial gas can be either toxic or medically useful</article-title><source>Mediators Inflamm</source><year>2004</year><volume>13</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15203558</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>Filippo C</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><name><surname>Capodanno</surname><given-names>P</given-names></name><name><surname>Ferraraccio</surname><given-names>F</given-names></name><name><surname>Coppola</surname><given-names>L</given-names></name><name><surname>Luongo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct</article-title><source>Inflamm Res</source><year>2008</year><volume>57</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">18827966</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sawalhi</surname><given-names>M</given-names></name><name><surname>Darwish</surname><given-names>H</given-names></name><name><surname>Mausouf</surname><given-names>M</given-names></name><name><surname>Shaheen</surname><given-names>A</given-names></name></person-group><article-title>Modulation of age-related changes in oxidative stress markers and energy status in the rat heart and hippocampus: a significant role for ozone therapy</article-title><source>Cell Biochem Funct</source><year>2013</year><volume>31</volume><fpage>518</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">23172693</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoloni</surname><given-names>M</given-names></name><name><surname>Di</surname><given-names>Sante L</given-names></name><name><surname>Cacchio</surname><given-names>A</given-names></name><name><surname>Apuzzo</surname><given-names>D</given-names></name><name><surname>Marotta</surname><given-names>S</given-names></name><name><surname>Razzano</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection</article-title><source>Spine (Phila Pa 1976)</source><year>2009</year><volume>34</volume><fpage>1337</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">19478653</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name></person-group><article-title>Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers</article-title><source>Oxid Med Cell Longev 2014</source><year>2014</year><fpage>273475</fpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecorelli</surname><given-names>A</given-names></name><name><surname>Bocci</surname><given-names>V</given-names></name><name><surname>Acquaviva</surname><given-names>A</given-names></name><name><surname>Belmonte</surname><given-names>G</given-names></name><name><surname>Gardi</surname><given-names>C</given-names></name><name><surname>Virgili</surname><given-names>F</given-names></name><etal/></person-group><article-title>NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells</article-title><source>Toxicol Appl Pharmacol</source><year>2013</year><volume>267</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">23253326</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>L</given-names></name><name><surname>Mart&#x000ed;nez-S&#x000e1;nchez</surname><given-names>G</given-names></name><name><surname>Bordicchia</surname><given-names>M</given-names></name><name><surname>Malcangi</surname><given-names>G</given-names></name><name><surname>Pocognoli</surname><given-names>A</given-names></name><name><surname>Morales-Segura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway <italic>in vivo</italic> ?A preliminary result</article-title><source>Eur J Pharmacol</source><year>2014</year><volume>742</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">25218903</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokozawa</surname><given-names>T</given-names></name><name><surname>Zheng</surname><given-names>PD</given-names></name><name><surname>Oura H</surname><given-names>FK</given-names></name></person-group><article-title>Animal model of adenine-induced chronic renal failure in rats</article-title><source>Nephron</source><year>1986</year><volume>44</volume><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">3785486</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokozawa</surname><given-names>T</given-names></name><name><surname>Oura</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>T</given-names></name></person-group><article-title>Metabolic effects of dietary purine in rats</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><year>1982</year><volume>28</volume><fpage>519</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">7161649</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon Fernandez</surname><given-names>OS</given-names></name><name><surname>Ajamieh</surname><given-names>HH</given-names></name><name><surname>Berlanga</surname><given-names>J</given-names></name><name><surname>Menendez</surname><given-names>S</given-names></name><name><surname>Viebahn-Hansler</surname><given-names>R</given-names></name><name><surname>Re</surname><given-names>L</given-names></name><etal/></person-group><article-title>Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion</article-title><source>Transpl Int</source><year>2008</year><volume>21</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">17927680</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrego</surname><given-names>A</given-names></name><name><surname>Zamora</surname><given-names>Z</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>R</given-names></name><name><surname>Romay</surname><given-names>C</given-names></name><name><surname>Men&#x000e9;ndez</surname><given-names>S</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>F</given-names></name><etal/></person-group><article-title>Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats</article-title><source>Mediators Inflamm</source><year>2004</year><volume>13</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">15203559</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholas</surname><given-names>SB</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Aminzadeh</surname><given-names>A</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name><name><surname>Crum</surname><given-names>A</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name></person-group><article-title>Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy</article-title><source>Am J Transl Res</source><year>2012</year><volume>4</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">22937204</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>ND</given-names></name><name><surname>Liu</surname><given-names>SM</given-names></name><name><surname>Lau</surname><given-names>WL</given-names></name><name><surname>Khazaeli</surname><given-names>M</given-names></name><name><surname>Nazertehrani</surname><given-names>S</given-names></name><name><surname>Farzaneh</surname><given-names>SH</given-names></name><etal/></person-group><article-title>High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e114881</fpage><pub-id pub-id-type="pmid">25490712</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminzadeh</surname><given-names>MA</given-names></name><name><surname>Nicholas</surname><given-names>SB</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name></person-group><article-title>Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy</article-title><source>Nephrol Dial Transplant</source><year>2013</year><volume>28</volume><fpage>2038</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">23512109</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borra</surname><given-names>SK</given-names></name><name><surname>Mahendra</surname><given-names>J</given-names></name><name><surname>Gurumurthy</surname><given-names>P</given-names></name><name><surname>Jayamathi Iqbal</surname><given-names>SS</given-names></name><name><surname>Mahendra</surname><given-names>L</given-names></name></person-group><article-title>Effect of curcumin against oxidation of biomolecules by hydroxyl radicals</article-title><source>J Clin Diagn Res</source><year>2014</year><volume>8</volume><fpage>CC01</fpage><lpage>05</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Small</surname><given-names>DM</given-names></name><name><surname>Coombes</surname><given-names>JS</given-names></name><name><surname>Bennett</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>DW</given-names></name><name><surname>Gobe</surname><given-names>GC</given-names></name></person-group><article-title>Oxidative stress, anti-oxidant therapies and chronic kidney disease</article-title><source>Nephrology (Carlton)</source><year>2012</year><volume>17</volume><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">22288610</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalle-Donne</surname><given-names>I</given-names></name><name><surname>Rossi</surname><given-names>F</given-names></name><name><surname>Giustarini</surname><given-names>D</given-names></name><name><surname>Milzani</surname><given-names>A</given-names></name><name><surname>Colombo</surname><given-names>R</given-names></name></person-group><article-title>Protein carbonyl groups as biomarkers of oxidative stress</article-title><source>Clin Chim Acta</source><year>2002</year><volume>329</volume><fpage>23</fpage><lpage>38</lpage></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehata</surname><given-names>NI</given-names></name><name><surname>Abd-Elgawad</surname><given-names>HM</given-names></name><name><surname>Mawsouf</surname><given-names>MN</given-names></name><name><surname>Shaheen</surname><given-names>AA</given-names></name></person-group><article-title>The potential role of ozone in ameliorating the age-related biochemical changes in male rat cerebral cortex</article-title><source>Biogerontology</source><year>2012</year><volume>13</volume><fpage>565</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">23001537</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koca</surname><given-names>K</given-names></name><name><surname>Yurttas</surname><given-names>Y</given-names></name><name><surname>Bilgic</surname><given-names>S</given-names></name><name><surname>Cayci</surname><given-names>T</given-names></name><name><surname>Topal</surname><given-names>T</given-names></name><name><surname>Durusu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats</article-title><source>J Surg Res</source><year>2010</year><volume>164</volume><fpage>e83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">20850777</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekici</surname><given-names>S</given-names></name><name><surname>Dogan</surname><given-names>Ekici AI</given-names></name><name><surname>Ozturk</surname><given-names>G</given-names></name><name><surname>Benli</surname><given-names>Aksungar F</given-names></name><name><surname>Sinanoglu</surname><given-names>O</given-names></name><name><surname>Turan</surname><given-names>G</given-names></name><etal/></person-group><article-title>Comparison of melatonin and ozone in the prevention of reperfusion injury following unilateral testicular torsion in rats</article-title><source>Urology</source><year>2012</year><volume>80</volume><fpage>899</fpage><lpage>906</lpage><pub-id pub-id-type="pmid">22950989</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>L</given-names></name><name><surname>Martinez-Sanchez</surname><given-names>G</given-names></name><name><surname>Bordicchia</surname><given-names>M</given-names></name><name><surname>Malcangi</surname><given-names>G</given-names></name><name><surname>Pocognoli</surname><given-names>A</given-names></name><name><surname>Morales-Segura</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway <italic>in vivo</italic>? A preliminary result</article-title><source>Eur J Pharmacol</source><year>2014</year><volume>742</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">25218903</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa</surname><given-names>I</given-names></name><name><surname>Kiyama</surname><given-names>S</given-names></name><name><surname>Yoshioka</surname><given-names>T</given-names></name></person-group><article-title>Renal antioxidant enzymes: their regulation and function</article-title><source>Kidney Int</source><year>1994</year><volume>45</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8126996</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaillant</surname><given-names>JD</given-names></name><name><surname>Fraga</surname><given-names>A</given-names></name><name><surname>Diaz</surname><given-names>MT</given-names></name><name><surname>Mallok</surname><given-names>A</given-names></name><name><surname>Viebahn-Hansler</surname><given-names>R</given-names></name><name><surname>Fahmy</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats</article-title><source>Eur J Pharmacol</source><year>2013</year><volume>714</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">23911887</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Xing</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury</article-title><source>Eur J Pharmacol</source><year>2008</year><volume>581</volume><fpage>306</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">18093583</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>ET</given-names></name><name><surname>Tergaonkar</surname><given-names>V</given-names></name></person-group><article-title>Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential</article-title><source>Clin Sci (Lond)</source><year>2009</year><volume>116</volume><fpage>451</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">19200055</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>QM</given-names></name></person-group><article-title>The IKK NF-kappa B system: a treasure trove for drug development</article-title><source>Nat Rev Drug Discov</source><year>2004</year><volume>3</volume><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">14708018</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Ozone therapy ameliorates tubulointerstitial inflammation by regulating TLR4 in adenine-induced CKD rats</article-title><source>Ren Fail 2016</source><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedruzzi</surname><given-names>LM</given-names></name><name><surname>Stockler-Pinto</surname><given-names>MB</given-names></name><name><surname>Leite</surname><given-names>M</given-names><suffix>Jr</suffix></name><name><surname>Mafra</surname><given-names>D</given-names></name></person-group><article-title>Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease?</article-title><source>Biochimie</source><year>2012</year><volume>94</volume><fpage>2461</fpage><lpage>2466</lpage><pub-id pub-id-type="pmid">22874821</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buelna-Chontal</surname><given-names>M</given-names></name><name><surname>Zazueta</surname><given-names>C</given-names></name></person-group><article-title>Redox activation of Nrf2 &#x00026;NF-kappaB: a double end sword?</article-title><source>Cell Signal</source><year>2013</year><volume>25</volume><fpage>2548</fpage><lpage>2557</lpage><pub-id pub-id-type="pmid">23993959</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>CC</given-names></name><name><surname>Li</surname><given-names>SJ</given-names></name><name><surname>Yang</surname><given-names>CL</given-names></name><name><surname>Xue</surname><given-names>RL</given-names></name><name><surname>Xi</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-kappaB Signaling Pathway</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>17784</fpage><lpage>17795</lpage><pub-id pub-id-type="pmid">26013831</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Lyu</surname><given-names>JH</given-names></name><name><surname>Song</surname><given-names>HH</given-names></name><name><surname>Jeong</surname><given-names>HS</given-names></name><name><surname>Ha</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Carthami Flos suppresses neutrophilic lung inflammation in mice, for which nuclear factor-erythroid 2-related factor-1 is required</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>470</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">24252335</pub-id></element-citation></ref></ref-list></back></article>